The invention provides a method for the production of a zeolite particle composition which has optimized characteristics, such as enhanced adsorption and specific ion exchange properties. A method and an apparatus for producing improved zeolite particle compositions are provided, where the particles are treated with an oxygen-containing gas during micronisation. The zeolite particle compositions can be used in a method for treatment of the human or animal body by therapy and/or prophylaxis, and specifically in a method of treating or preventing conditions of the human or animal body or symptoms of these conditions that are related to heavy metals, endotoxins, exotoxins, and/or bacterial, viral or parasitic intoxications in or of the digestive system, mucosal surfaces or the skin. Also, new zeolite particle compositions can be used as food additive, as filter for purification of water, in packaging materials, or as cosmetic ingredient.

A method of making a population of capsules, the capsules can include a core including a benefit agent and a shell surrounding the core, wherein the shell can include a first shell component.

Disclosed is a powder composition consisting essentially of Magnolia officinalis bark extract comprising magnolol and honokiol, tocopherol or tocopherol acetate, lecithin, at least one gum, and optionally water, wherein the composition is in powdered form.

The invention provides a cosmetic base having an unprecedented appearance and feeling on use, in particular a cosmetic base with a novel feeling on use that gives a fresh feeling and a unique feel as the cosmetic softly bursts and collapses, allowing water to flow out, when applied to the skin, and a skin cosmetic using the same. A cosmetic base includes (A) 0.15-0.6 mass % of sodium acrylate-grafted starch and (B) 0.25-1.35 mass % of an associative thickener having a polyoxyalkylene chain wherein the total amount of the (A) sodium acrylate-grafted starch and (B) associative thickener having a polyoxyalkylene chain compounded is 0.5-1.5 mass % and to a skin cosmetic that uses the cosmetic base.

A protein transduction domain and a fusion compound, which are more efficient, are proposed. As a result of selecting and testing a number of candidate peptides, the present inventors found that a GK1 peptide comprising 18 amino acids and a modified sequence obtained by replacing, adding, or deleting some sequences are bonded to high-molecular-weight materials such as proteins based on the basic sequence of the peptide, thus enabling the high-molecular-weight materials to smoothly penetrate into living bodies, for example, cells, tissues, or blood. A fusion compound, oligonucleotide, or vector using the same may be applied as a pharmaceutical composition for preventing or treating diseases.

A composition comprising hydroxyalkyl starch having an amylose content of at least 30 wt% and the weight average molar mass in the range of about 10.sup.5 - 10.sup.8 g/mol, a salt which is selected from the group consisting of an alkaline metal salt and/or alkaline earth metal salt, and water. The preferably viscous formulation is especially suitable in the field of agriculture, horticulture and forestry to increase plant production efficiency by forming a film which reduces the wash-off of plant protection products, stimulants and fertilizers, or reduces erosion by soil bonding and dust formation in seed coating and animal husbandry. Furthermore, the formulation is applicable as replacer of synthetic polymers in cosmetics and personal care products.

The present disclosure relates to water-soluble formulations containing cannabinoids. In particular, the formulations comprise at least one isolated cannabinoid, cannabinoid oil or cannabinoid resin, and a solubilizing agent of Formula (I), where the group X is a residue of a hydrophobic moiety selected from sterols, tocopherols, and derivatives thereof, and the group Y is a residue of a hydrophilic moiety selected from polyalcohols, polyethers, and derivatives thereof. In preferred embodiments, the cannabinoid comprises cannabidiol (CBD) or Δ9-tetrahydrocannabinol (THC) and the hydrophobic moiety is polyoxyethanyl-α-tocopheryl sebacate (TPS). In embodiments, the formulations comprise a carrier oil, such as a medium length triglyceride (MCT), and are dispersed in water in the form of micelles.

Populations of benefit agent delivery particles are disclosed, the particles having a core and a shell encapsulating the core, the shell comprising certain multifunctional (meth)acrylate-based polymers, along with processes for making and uses of such compositions. The delivery particle has a core to polymer wall ratio by weight from about 96:4 to about 99.5 to 0.5 and a volume-weighted particle size from about 30 to about 50 microns. The compositions deliver core content with a desired delivery profile, such as fragrance delivery at desired touchpoints with higher efficiency. The delivery particle has high pay load, yet exhibits decreased benefit agent leakage, and provides a desired delivery profile.

Storage stable organopolysiloxane gels, preparable in commercial quantities are prepared by the hydrosilylation reaction of a silicone resin containing a hydrosilyatable group, a short chain Si—H-functional silicone, and a long chain Si—H-functional silicone.

High throughput cell free protein synthesis methods and systems are provided for expression of active, mature enzymes and proteins derived from zymogens and proproteins. Zymogens and proproteins are expressed in their mature, active form in a cell free expression system, without cleavage of a pro-sequence to produce the active polypeptide.